A brain-boosting milkshake that is said to reduce symptoms of early Alzheimer's goes on sale in the UK Monday, it was announced here. "Souvenaid", which costs 3.49 pounds per 125 ml bottle, contains a cocktail of nutrients needed to build new connections in the brain, the makers said. The makers, Nutricia, claim the once-a-day product has been clinically shown to improve memory in mildly affected patients. Prof. Clive Ballard, director of research at the Alzheimer's Society, however, urged people to spend their money elsewhere. "People shouldn't get excited that an off-the-shelf drink is going to transform the lives of people with dementia," he said. Around 800,000 people in the UK are living with dementia, more than half with Alzheimer's disease. As the population ages, the number of dementia sufferers is expect to soar to 1.7 million by 2051, the health authorities said. Souvenaid is said to be the result of more than a decade of research into the nutritional needs of people with early Alzheimer's. A key feature of the disease is the loss of synapses, or connections in the brain, which are vital to memory. People with Alzheimer's are known to lack certain nutrients necessary for synapse-building, it is noted. Souvenaid is therefore designed to boost levels of these nutrients. In a randomly controlled clinical trial involving 259 patients from six European countries, Souvenaid produced statistically significant improvements in episodic memory over 24 weeks. This is the memory of life events occurring at specific times and places, such as a birthday party. As of today, the drink will be sold in pharmacies throughout England, Scotland and Wales. Prof Ballard said that "While past studies of this product have showed some benefits for memory, there is no evidence that it has an effect on other aspects of thinking or everyday life, and there was also no benefit on other symptoms of dementia.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor